These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35896206)

  • 1. Risk assessment of systemic sclerosis-associated pulmonary arterial hypertension: cardiac index
    Hassan HJ; Naranjo M; Kazzi B; Housten-Harris T; Hsu S; Balasubramanian A; Simpson CE; Damico RL; Kolb TM; Mathai SC; Hassoun PM
    Eur Respir J; 2022 Sep; 60(3):. PubMed ID: 35896206
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic Sclerosis and Pulmonary Hypertension: The Great Masquerader.
    Baratto C; Caravita S; Battista Perego G; Badano LP; Vachiéry JL; Parati G
    Circ Heart Fail; 2021 Feb; 14(2):e007554. PubMed ID: 33504158
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.
    Weatherald J; Boucly A; Launay D; Cottin V; Prévot G; Bourlier D; Dauphin C; Chaouat A; Savale L; Jaïs X; Jevnikar M; Traclet J; De Groote P; Simonneau G; Hachulla E; Mouthon L; Montani D; Humbert M; Sitbon O
    Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30209196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension.
    Tedford RJ; Mudd JO; Girgis RE; Mathai SC; Zaiman AL; Housten-Harris T; Boyce D; Kelemen BW; Bacher AC; Shah AA; Hummers LK; Wigley FM; Russell SD; Saggar R; Saggar R; Maughan WL; Hassoun PM; Kass DA
    Circ Heart Fail; 2013 Sep; 6(5):953-63. PubMed ID: 23797369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary hypertension in systemic sclerosis: diagnosis by systematic screening and prognosis after three years follow-up.
    Vilela VS; Dias MM; Salgado ÂA; da Silva BRA; Lopes AJ; Bessa EJC; Bruno LP; da Costa CH; Levy RA; Rufino R
    BMC Pulm Med; 2021 Jul; 21(1):251. PubMed ID: 34325685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heart involvement and pulmonary arterial hypertension in patients with systemic sclerosis].
    Cikes N
    Reumatizam; 2010; 57(2):99-104. PubMed ID: 21875012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic and Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: A Comparison of Demographic, Hemodynamic, and MRI Characteristics and Outcomes.
    Ramjug S; Hussain N; Hurdman J; Billings C; Charalampopoulos A; Elliot CA; Kiely DG; Sabroe I; Rajaram S; Swift AJ; Condliffe R
    Chest; 2017 Jul; 152(1):92-102. PubMed ID: 28223154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Survival for Patients with Systemic Sclerosis-associated Pulmonary Arterial Hypertension: For Real?
    Xanthouli P
    Am J Respir Crit Care Med; 2023 Feb; 207(3):238-240. PubMed ID: 36383981
    [No Abstract]   [Full Text] [Related]  

  • 9. On the diagnostic test accuracy of N-terminal pro-brain natriuretic peptide (NT-proBNP) for pulmonary arterial hypertension in patients with systemic sclerosis. Comment on: "Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: a systematic review and meta-analysis" by Zhang et al. Joint Bone Spine 2021:105287.
    Simopoulou T; Grammatikopoulou MG; Gkiouras K; Bogdanos DP
    Joint Bone Spine; 2022 May; 89(3):105317. PubMed ID: 34875375
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.
    Someya F; Mugii N; Oohata S
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):152-156. PubMed ID: 27463117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension phenotypes in patients with systemic sclerosis.
    Haque A; Kiely DG; Kovacs G; Thompson AAR; Condliffe R
    Eur Respir Rev; 2021 Sep; 30(161):. PubMed ID: 34407977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pulmonary hypertension screening in systemic sclerosis: The best strategy remains to be defined].
    Launay D; Sobanski V
    Rev Med Interne; 2017 Aug; 38(8):499-501. PubMed ID: 28623031
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung or Heart-Lung Transplant in Pulmonary Arterial Hypertension: What Is the Impact of Systemic Sclerosis?
    Gadre SK; Minai OA; Wang XF; Zhang Q; Budev M; Tonelli AR
    Exp Clin Transplant; 2017 Dec; 15(6):676-684. PubMed ID: 28540841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pulmonary hypertension in patients with systemic sclerosis].
    Ciurzyński M; Bienias P; Pruszczyk P
    Kardiol Pol; 2007 Aug; 65(8):994-1000. PubMed ID: 17853323
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
    Lewis C; Sanderson R; Vasilottos N; Zheutlin A; Visovatti S
    Heart Fail Clin; 2023 Jan; 19(1):45-54. PubMed ID: 36435572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A documented episode of pulmonary vasoconstriction in systemic sclerosis.
    Naslund MJ; Pearson TA; Ritter JM
    Johns Hopkins Med J; 1981 Feb; 148(2):78-80. PubMed ID: 7206403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of pulmonary arterial hypertension-targeted therapy in systemic sclerosis.
    Lee MH; Bull TM
    F1000Res; 2019; 8():. PubMed ID: 32025283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals--a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes.
    Kanski M; Arheden H; Wuttge DM; Bozovic G; Hesselstrand R; Ugander M
    J Cardiovasc Magn Reson; 2013 Sep; 15(1):86. PubMed ID: 24066703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.